Skip to main content
Femtobiomed Inc. logo

Femtobiomed Inc. — Investor Relations & Filings

Ticker · 327610 ISIN · KR7327610002 KO Professional, scientific and technical activities
Open in API
Filings indexed 201 across all filing types
Latest filing 2025-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 327610

About Femtobiomed Inc.

https://www.femtobiomed.com/

Femtobiomed Inc. is a cell engineering company that develops technologies for the cell and gene therapy industry. The company's core offering is the CellShot® platform, a proprietary, non-viral intracellular delivery system. This platform utilizes a patented technology known as 'Partitioned Flow Transfection,' which functions as a three-dimensional nanoinjection system for the direct, cargo-free delivery of biomolecules into individual cells. The technology is designed to support the discovery and development of advanced therapeutics, including anti-cancer treatments, for the healthcare and research sectors. Femtobiomed aims to pioneer non-viral cell engineering to accelerate the creation of novel cell therapies.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) by FemtoBiomed. It provides a summary of the audit opinion (unqualified/appropriate) and key financial data (assets, liabilities, revenue, etc.) as required by regulatory disclosure standards. While it contains financial data, it is a short-form regulatory disclosure announcing the receipt and submission of the audit report rather than the full audit report document itself. Therefore, it fits the definition of a Report Publication Announcement (RPA). FY 2024
2025-03-18 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for FemtoBiomed. It contains the agenda for the upcoming Annual General Meeting (AGM), including financial statement approval, director appointments, and governance changes. In the context of US-style regulatory filings, this is equivalent to a Proxy Statement (DEF 14A), which provides shareholders with the information necessary to vote on matters at the meeting. Since it is a formal solicitation of votes and information for a shareholder meeting, it is classified as a Proxy Solicitation & Information Statement.
2025-03-07 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by FemtoBioMed. It outlines the date, location, and specific agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes.
2025-02-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (e.g., market trades, stock option cancellations), and updated shareholding percentages. This falls under the category of Major Shareholding Notification.
2025-02-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (e.g., open market trading), and reasons for changes (e.g., resignation of an executive). This falls under the category of Major Shareholding Notification.
2025-01-07 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the administrative procedure required for the meeting. Given it is a standard regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2024-12-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.